Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation.
Ip W, Silva JMF, Gaspar H, Mitra A, Patel S, Rao K, Chiesa R, Amrolia P, Gilmour K, Ahsan G, Slatter M, Gennery AR, Wynn RF, Veys P, Qasim W.
Ip W, et al. Among authors: patel s.
Cytotherapy. 2018 Jun;20(6):830-838. doi: 10.1016/j.jcyt.2018.03.040. Epub 2018 May 9.
Cytotherapy. 2018.
PMID: 29753677
Clinical Trial.